Impact of COVID-19 on Thyroid Hormones

Authors

1 Lecturer of Internal Medicine Department ALAzhar University, Faculty of Medicine, Assuit, Egypt

2 Internal medicine department ALAzhar University, Faculty of Medicine, Assuit, Egypt

3 Professor of Internal Medicine Department ALAzhar University, Faculty of Medicine, Assuit, Egypt

4 Lecturer of Critical care medicine department, Faculty of Medicine Menoufia university, Menoufia, Egypt

Abstract

Background: Hypothyroidism is a significant endocrine condition. It addresses roughly 30 to 40% of patients found in endocrinology Aim: intended to examine thyroid hormones in COVID-19-positive patent patients. Methods and Patients: This cross-sectional study included 200 Assiut patients admitted to isolation hospitals with a confirmed COVID-19 infection. Results: were compared and assessed for each patient: In intensive care, 182 patients improved, while 18 died. The study lasted anywhere from one to twelve months. The average TSH level was 1.28 0.714 IU/ml, while the average free T4 level was 1.36 0.624 ng/dL and the average free T3 level was 2.29 0.783 pg/ml, respectively. 68% of patients had hypothyroidism, while 32% of patients had normal thyroid function. 9 percent of patients survived, and 91% were cured. Heart rate and RR are not significantly different between the groups. comorbidities studied showed statistically significant differences between the groups. Massive contrast between bunches for D. dimer and ferritin, ALT, AST, egg whites, TSH and free T3. Conclusion: Thyroid hormones are affected by COVID-19. In terms of TSH and free T3, survivors and deceased individuals differ significantly. decline in TSH and FT3 more in perished patients than in enduring patients).

Files

Share

How to cite

Statistics